FNIH 2023 HEALTH IMPACT REPORT
Accelerating New Therapies

New Public-Private Partnership Supports Development of Pediatric Medical Devices

banner

Despite efforts to support innovation in pediatric medical devices (PMD), challenges remain in developing these technologies for children, including concerns about device longevity and long-term exposure to implanted materials.

Pathway to Impact:

  • The FNIH announced the launch of a project design phase to address the gap in availability of these devices. The project is supported by a public-private partnership between the NIH, the U.S. Food and Drug Administration, the Biomedical Advanced Research and Development Authority, and partners from the private sector.
  • A full-scale PMD public-private partnership project will follow the design phase, with the goal of developing a sustainable infrastructure for creating and commercializing these devices.

“A national ecosystem that supports the development of pediatric medical devices from idea to patient use is critical to address the needs of pediatric populations. At FNIH, we are excited to support this public-private partnership that brings together all stakeholders in pediatric device development, distribution, and use to solve the health challenges affecting these kids and their families.”

Joseph P. Menetski, PhD, Senior Vice President, Chief Translational Science Officer, at the FNIH
2023 Health Impact Report Home